Treatment of primary insomnia

The Journal of the American Board of Family Practice
Erika N RingdahlJohn E Delzell

Abstract

Ten percent to 40% of adults have intermittent insomnia, and 15% have long-term sleep difficulties. This article provides a review of the classification, differential diagnosis, and treatment options available for insomnia. We performed a MEDLINE search using OVID and the key words "insomnia," "sleeplessness," "behavior modification," "herbs," "medicinal," and "pharmacologic therapy." Articles were selected based on their relevance to the topic. Evaluation of insomnia includes a careful sleep history, review of medical history, review of medication use (including over-the-counter and herbal medications), family history, and screening for depression, anxiety, and substance abuse. Treatment should be individualized based on the nature and severity of symptoms. Nonpharmacologic treatments are effective and have minimal side effects compared with drug therapies. Medications such as diphenhydramine, doxylamine, and trazodone can be used initially, but patients may not tolerate their side effects. Newer medications such as zolpidem and zaleplon have short half-lives and minimal side effects. Both are approved for short-term use in the insomniac.

Citations

May 11, 2005·IDrugs : the Investigational Drugs Journal·Erik Holzinger
Aug 12, 2006·Current Treatment Options in Neurology·Philip M Becker
Sep 12, 2009·Current Treatment Options in Neurology·Philip M Becker, Muhammad Sattar
Mar 31, 2010·Behavioral Sleep Medicine·Kathleen A FoleyJames K Walsh
May 9, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Norman WolkoveMark Palayew
Aug 30, 2005·Issues in Mental Health Nursing·Kathryn A Lee, Teresa M Ward
May 10, 2011·Expert Opinion on Investigational Drugs·D Alan Lankford
Jul 13, 2006·Current Medical Research and Opinion·Larry Culpepper
Oct 25, 2011·Sleep Medicine·Giselle Soares PassosMarco Túlio de Mello
Dec 1, 2009·Obstetrics and Gynecology Clinics of North America·Maria MuzikHeather Flynn
Feb 24, 2009·Primary Care·Sheila M Marcus, Julie E Heringhausen
Oct 26, 2005·Neurologic Clinics·Philip M Becker
Jan 6, 2009·Journal of the American Academy of Nurse Practitioners·Preetha Krishnan, Pamela Hawranik
Jul 13, 2012·The Mount Sinai Journal of Medicine, New York·Matthew R Ebben, Mariya Narizhnaya
Sep 5, 2006·General Hospital Psychiatry·Gregory E Simon, Evette J Ludman
Jun 30, 2015·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Wei-Wei WuXiao-Ying Jiang
Dec 11, 2014·Journal of the American Society of Hypertension : JASH·Charlene E GamaldoRachel Marie E Salas
Sep 3, 2013·Epilepsy Research and Treatment·Vladimir Shvarts, Steve Chung
Oct 19, 2016·Clinical Therapeutics·Jennifer L SchroeckKari A Mergenhagen
Apr 28, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·David B BanksRonald E Cannon
Feb 26, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Hazel EverittPaul Little
Feb 8, 2007·The American Journal of Clinical Nutrition·Ahmad AfaghiChin Moi Chow
Aug 24, 2007·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Giselle Soares PassosMarco Túlio de Mello
Aug 5, 2005·Current Treatment Options in Neurology·Chien-Ming YangYu-Shu Huang
Nov 6, 2018·Neuroscience and Biobehavioral Reviews·John A CaldwellHarris R Lieberman
Aug 12, 2021·São Paulo Medical Journal = Revista Paulista De Medicina·Antônio Evaldo Dos SantosRoberto Jerônimo Dos Santos Silva

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved